<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00632411</url>
  </required_header>
  <id_info>
    <org_study_id>524</org_study_id>
    <secondary_id>R18HL053478-07A2</secondary_id>
    <nct_id>NCT00632411</nct_id>
  </id_info>
  <brief_title>Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study)</brief_title>
  <acronym>AFIII</acronym>
  <official_title>Efficacy of a Smoking Quit Line in the Military</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tennessee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Tennessee</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rates of cigarette smoking in the military are high. Tobacco telephone quit lines are
      telephone-based services that provide information and guidance to people who want to quit
      smoking. This study will evaluate the effectiveness of a tobacco quit line program, in
      addition to nicotine replacement patches, at helping people in the military quit smoking
      cigarettes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Active duty military personnel are at high risk of cigarette smoking. Despite strong efforts
      by the Department of Defense to reduce tobacco use, rates of smoking among people in the
      military remain high. The military lifestyle presents unique challenges to implementing
      smoking cessation programs, including the high mobility of troops, remote locations, and
      limited access to healthcare services. Because of these challenges, many smoking cessation
      programs that are effective in the non-military population are often ineffective in the
      military population. Tobacco telephone quit lines are telephone-based tobacco cessation
      services that provide easy access to educational materials, referrals to local programs, and
      individualized telephone counseling. Because tobacco quit lines are remotely based and can
      fit into varying schedules at convenient times, they may be effective among people in the
      military. Nicotine replacement patches are another effective smoking cessation tool and can
      be used in addition to telephone quit lines. The purpose of this study is to evaluate the
      effectiveness of tobacco quit lines, in addition to nicotine replacement patches, at
      improving smoking cessation rates among members of the Air Force.

      This study will enroll military healthcare beneficiaries who have smoked at least five
      cigarettes a day in the year before study entry. Participants will be randomly assigned to
      either a proactive group, in which study researchers will initiate contact with the
      participants, or a reactive group, in which participants will initiate contact with the
      researchers. In this six-session program, phone calls will occur at 1- to 2-week intervals
      over an 8-week period. The phone sessions will focus on cutting down on cigarette smoking,
      setting a quit date, and relapse prevention. All participants will receive nicotine
      replacement patches after the second session is completed. The reactive group will receive
      two weeks of nicotine replacement patches and the proactive group will receive 8 weeks of
      nicotine replacement patches. At the end of session four and 1 year later, study staff will
      call participants to collect information on tobacco abstinence, nicotine replacement patch
      use adherence, and other smoking cessation medication use.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Continuous Abstinence</measure>
    <time_frame>Measured at Year 1</time_frame>
    <description>No cigarette smoking since two weeks after the target quit date.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1298</enrollment>
  <condition>Smoking</condition>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Proactive group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Research study staff will contact participant to initiate the program. Half of participants will be randomized to the proactive condition and the other half to the reactive conditions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reactive group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant will contact the research study staff to initiate the program.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine Patch</intervention_name>
    <description>Participants who smoke more than 20 cigarettes per day will use a 21-mg patch for 4 weeks, a 14-mg patch for the next 2 weeks, a 7-mg patch for the next 2 weeks, and then no patch.
Participants who smoke between 10 to 19 cigarettes per day will use a 14-mg patch for 4 weeks, a 7-mg patch for the next 4 weeks, and then no patch.
Participants who smoke between 5 to 9 cigarettes per day will use a 7-mg patch for 8 weeks and then no patch.
The proactive group will be given 8 weeks of patch treatment and the reactive group will be given 2 weeks of patch treatment.</description>
    <arm_group_label>Proactive group</arm_group_label>
    <arm_group_label>Reactive group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tobacco Quit Line Program</intervention_name>
    <description>Phone session 1 will focus on smoking reduction.
Phone session 2 will focus on preparing to quit and surviving the first days as a non-smoker. A quit date will be set in 7 to 10 days. Nicotine patches will be sent to participant with detailed instructions for patch use.
Phone session 3 will focus on the first days after the quit date.
Phone session 4 will focus on a review of progress and challenges of quitting. Plans to manage high-risk situations will be discussed.
Phone session 5 will focus on short-term relapse prevention.
Phone session 6 will focus on long-term relapse prevention.</description>
    <arm_group_label>Proactive group</arm_group_label>
    <arm_group_label>Reactive group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Department of Defense healthcare beneficiary

          -  Has smoked five or more cigarettes per day for at least 1 year before study entry

          -  Must be at least eighteen years old

        Exclusion Criteria:

          -  Known allergy or sensitivity to nicotine replacement therapy

          -  No telephone

          -  Inability to understand consent procedures

          -  Basic Military Trainee
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert C. Klesges, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tennessee Health Science Center and St. Jude Childrens' Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Harry Lando, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerald W. Talcott, Ph.D. Colonel (Ret.)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wilford Hall Medical Center; University of Tennessee Health Science Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Tennessee Health Science Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wilford Hall Medical Center</name>
      <address>
        <city>Lackland Air Force Base</city>
        <state>Texas</state>
        <zip>78236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002 Apr 12;51(14):300-3.</citation>
    <PMID>12002168</PMID>
  </reference>
  <reference>
    <citation>Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004 Mar 10;291(10):1238-45. Review. Erratum in: JAMA. 2005 Jan 19;293(3):298. JAMA. 2005 Jan 19;293(3):293-4.</citation>
    <PMID>15010446</PMID>
  </reference>
  <reference>
    <citation>Bray RM, Hourani LL, Rae KL, al. e: Department of Defense Survey of Health Related Behaviors Among Military Personnel, in Report No. RTI/7841/006-FR, Research Triangle Park, NC, RTI International, 2003</citation>
  </reference>
  <reference>
    <citation>U.S. Department of Health and Human Services: The health consequences of smoking; a report of the surgeon general., in, Atlanta, GA, USDHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease and Prevention and Health Promotion, Office on Smoking and Health, 2004</citation>
  </reference>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults--United States, 2002. MMWR Morb Mortal Wkly Rep. 2004 May 28;53(20):427-31.</citation>
    <PMID>15163928</PMID>
  </reference>
  <reference>
    <citation>Department of Defense: Tobacco use prevention strategic plan., in, Washington, D.C., Department of Defense, 1999</citation>
  </reference>
  <reference>
    <citation>Department of Defense: Smoking in DoD occupied buildings and facilities., in, Washington, DC, Department of Defense, 1977, p Instruction No. 6015.6018</citation>
  </reference>
  <reference>
    <citation>Department of Defense: Health promotion., in, Washington, D.C., Department of Defense, 1994b, pp Directive No. 1010.1010 (1010.1010 supersedes and cancels March 1011, 1986, version of Directive No. 1010.1010)</citation>
  </reference>
  <reference>
    <citation>Department of Defense: DoD food and nutrition research, development, testing, evaluation, and engineering program., in, Washington, D.C., Department of Defense, 1983, p Instruction No. 3235.3232</citation>
  </reference>
  <reference>
    <citation>Conway TL, Woodruff SI, Edwards CC, Elder JP, Hurtado SL, Hervig LK. Operation Stay Quit: evaluation of two smoking relapse prevention strategies for women after involuntary cessation during US Navy recruit training. Mil Med. 2004 Mar;169(3):236-42.</citation>
    <PMID>15080246</PMID>
  </reference>
  <reference>
    <citation>Cronan TA, Conway TL, Hervig LK. Evaluation of smoking interventions in recruit training. Mil Med. 1989 Jul;154(7):371-5.</citation>
    <PMID>2503780</PMID>
  </reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2008</study_first_submitted>
  <study_first_submitted_qc>March 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2008</study_first_posted>
  <results_first_submitted>September 28, 2016</results_first_submitted>
  <results_first_submitted_qc>April 21, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 24, 2017</results_first_posted>
  <last_update_submitted>February 14, 2018</last_update_submitted>
  <last_update_submitted_qc>February 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Proactive Group</title>
          <description>Study staff will initiate contact to conduct 6 individual counseling sessions.
Participants will receive 8 weeks of Nicotine Replacement Therapy in the form of a patch.</description>
        </group>
        <group group_id="P2">
          <title>Reactive Group</title>
          <description>Participant will initiate contact with participant to conduct 6 individual counseling sessions.
Participants will receive 2 weeks of Nicotine Replacement Therapy in the form of a patch.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="649"/>
                <participants group_id="P2" count="649"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="489"/>
                <participants group_id="P2" count="473"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="160"/>
                <participants group_id="P2" count="176"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Proactive Group</title>
          <description>Research study staff will contact participant to initiate sessions.
8 weeks of Nicotine Replacement Therapy in the form of patch will be distributed this group.
Six sessions will be proactively delivered to the participant.
Phone session 1 will focus on smoking reduction.
Phone session 2 will focus on preparing to quit and surviving the first days as a non-smoker. A quit date will be set in 7 to 10 days.
Phone session 3 will focus on the first days after the quit date.
Phone session 4 will focus on a review of progress and challenges of quitting. Plans to manage high-risk situations will be discussed.
Phone session 5 will focus on short-term relapse prevention.
Phone session 6 will focus on long-term relapse prevention.</description>
        </group>
        <group group_id="B2">
          <title>Reactive Group</title>
          <description>Participant will contact the research study staff to initiate sessions.
2 weeks of Nicotine Replacement Therapy in the form of patch will be distributed this group.
Six sessions will be delivered to the participant as long as the participant calls to initiate the sessions.
Phone session 1 will focus on smoking reduction.
Phone session 2 will focus on preparing to quit and surviving the first days as a non-smoker. A quit date will be set in 7 to 10 days.
Phone session 3 will focus on the first days after the quit date.
Phone session 4 will focus on a review of progress and challenges of quitting. Plans to manage high-risk situations will be discussed.
Phone session 5 will focus on short-term relapse prevention.
Phone session 6 will focus on long-term relapse prevention.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="649"/>
            <count group_id="B2" value="649"/>
            <count group_id="B3" value="1298"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="649"/>
                    <measurement group_id="B2" value="649"/>
                    <measurement group_id="B3" value="1298"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.59" spread="13.65"/>
                    <measurement group_id="B2" value="39.42" spread="13.82"/>
                    <measurement group_id="B3" value="39.50" spread="13.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="291"/>
                    <measurement group_id="B2" value="271"/>
                    <measurement group_id="B3" value="562"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="358"/>
                    <measurement group_id="B2" value="378"/>
                    <measurement group_id="B3" value="736"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="124"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="585"/>
                    <measurement group_id="B2" value="588"/>
                    <measurement group_id="B3" value="1173"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="75"/>
                    <measurement group_id="B3" value="160"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="493"/>
                    <measurement group_id="B2" value="509"/>
                    <measurement group_id="B3" value="1002"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="649"/>
                    <measurement group_id="B2" value="649"/>
                    <measurement group_id="B3" value="1298"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Continuous Abstinence</title>
        <description>No cigarette smoking since two weeks after the target quit date.</description>
        <time_frame>Measured at Year 1</time_frame>
        <population>Participants</population>
        <group_list>
          <group group_id="O1">
            <title>Proactive Group</title>
            <description>Study staff will initiate contact to conduct 6 individual counseling sessions.
Participants will receive 8 weeks of Nicotine Replacement Therapy in the form of a patch.</description>
          </group>
          <group group_id="O2">
            <title>Reactive Group</title>
            <description>Participant will initiate contact with participant to conduct 6 individual counseling sessions.
Participants will receive 2 weeks of Nicotine Replacement Therapy in the form of a patch.</description>
          </group>
        </group_list>
        <measure>
          <title>Continuous Abstinence</title>
          <description>No cigarette smoking since two weeks after the target quit date.</description>
          <population>Participants</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="521"/>
                <count group_id="O2" value="529"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173"/>
                    <measurement group_id="O2" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Proactive Group</title>
          <description>Study staff will initiate contact to conduct 6 individual counseling sessions.
Participants will receive 8 weeks of Nicotine Replacement Therapy in the form of a patch.</description>
        </group>
        <group group_id="E2">
          <title>Reactive Group</title>
          <description>Participant will initiate contact with participant to conduct 6 individual counseling sessions.
Participants will receive 2 weeks of Nicotine Replacement Therapy in the form of a patch.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="649"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="649"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="307" subjects_at_risk="649"/>
                <counts group_id="E2" subjects_affected="98" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Increased Heart Rate/Heart Palpitations</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="649"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="649"/>
              </event>
              <event>
                <sub_title>Elevated Blood Pressure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="649"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ringing in Ears</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="649"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="649"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Ear Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="649"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Skin Rash</sub_title>
                <counts group_id="E1" events="88" subjects_affected="88" subjects_at_risk="649"/>
                <counts group_id="E2" events="26" subjects_affected="26" subjects_at_risk="649"/>
              </event>
              <event>
                <sub_title>Sleep Disturbance</sub_title>
                <counts group_id="E1" events="64" subjects_affected="64" subjects_at_risk="649"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="649"/>
              </event>
              <event>
                <sub_title>Stomach illness/Nausea/Diarrhea</sub_title>
                <counts group_id="E1" events="30" subjects_affected="30" subjects_at_risk="649"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="649"/>
              </event>
              <event>
                <sub_title>Pain/Joint Pain/Muscle Aches/ Back Pain</sub_title>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="649"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="649"/>
              </event>
              <event>
                <sub_title>Injury: knee/foot</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="649"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue/Lethargy</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="649"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety/Irritability</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="649"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="649"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="649"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection, Bladder problems</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="649"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory illness/ Sinus/ Sore throat/ Cold/Flu/Seasonal allergies</sub_title>
                <counts group_id="E1" events="55" subjects_affected="55" subjects_at_risk="649"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin biopsy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="649"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Gall bladder surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="649"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="649"/>
              </event>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="649"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="649"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Robert Klesges</name_or_title>
      <organization>University of Tennessee Health Science Center</organization>
      <phone>901-448-3174</phone>
      <email>lcolvin1@uthsc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

